Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

• Status: Completed
• Trial end date: 2005-04-01

Summary

Study to assess the effects of tegaserod added to PPI therapy in the resolution of heartburn and regurgitation in patients with incomplete relief from PPIs .

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Proton Pump Inhibitors; Tegaserod